Cite
Palaiodimou L, Stefanou MI, Katsanos AH, et al. Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur J Neurol. 2021;28(10):3517-3529doi: 10.1111/ene.14860.
Palaiodimou, L., Stefanou, M. I., Katsanos, A. H., Fragkou, P. C., Papadopoulou, M., Moschovos, C., Michopoulos, I., Kokotis, P., Bakirtzis, C., Naska, A., Vassilakopoulos, T. I., Chroni, E., Tsiodras, S., & Tsivgoulis, G. (2021). Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. European journal of neurology, 28(10), 3517-3529. https://doi.org/10.1111/ene.14860
Palaiodimou, Lina, et al. "Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis." European journal of neurology vol. 28,10 (2021): 3517-3529. doi: https://doi.org/10.1111/ene.14860
Palaiodimou L, Stefanou MI, Katsanos AH, Fragkou PC, Papadopoulou M, Moschovos C, Michopoulos I, Kokotis P, Bakirtzis C, Naska A, Vassilakopoulos TI, Chroni E, Tsiodras S, Tsivgoulis G. Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur J Neurol. 2021 Oct;28(10):3517-3529. doi: 10.1111/ene.14860. Epub 2021 Apr 28. PMID: 33837630; PMCID: PMC8250909.
Copy
Download .nbib